Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3β pathway in lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3β pathway in lung adenocarcinoma

Published:2019-04 Issue: Volume:86 Page:233-242
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Wang Yixuan,Piao Junjie,Wang Qianrong,Cui Xuelian,Meng Ziqi,Jin Tiefeng,Lin Zhenhua

Funder

National Natural Science Funds of China

Key Laboratory of the Science and Technology Department of Jilin Province

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference29 articles.

1. Cancer incidence and mortality in China, 2014;Chen;Chin J Cancer Res,2018

2. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

3. Non–small cell lung cancer;Ettinger;J Natl Compr Canc Netw,2010

4. Lung cancer;Herbst;N Engl J Med,2008

5. Metastasis-suppressor genes: a review and perspective on an emerging field;Yoshida;J Natl Cancer Inst,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. YAP1-activated ZNF131 promotes hepatocellular carcinoma cell proliferation through transcriptional regulation of PAIP1;Archives of Biochemistry and Biophysics;2024-04

2. A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax;HemaSphere;2024-02

3. Loss of Paip1 causes translation reduction and induces apoptotic cell death through ISR activation and Xrp1;Cell Death Discovery;2023-08-05

4. PAIP1 regulates expression of immune and inflammatory response associated genes at transcript level in liver cancer cell;PeerJ;2023-04-21

5. CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells;Current Issues in Molecular Biology;2022-04-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3